[Congenital mesoblastic nephroma: a clinicopathologic study of five cases].
Congenital mesoblastic nephroma (CMN) accounts for approximately 5% of paediatric renal tumours with the highest peak of incidence during the first 3 postnatal months. CMN almost always has a favourable prognosis. Therefore, CMN needs to be correctly diagnosed and differentiated, principally histologically, from other pediatric neoplasms. We present a clinicopathologic study of 5 cases of CMN.
Woźniak
Zdzisław Michał
ZM
Katedra i Zakład Anatomii Patologicznej, Akademia Medyczna, ul. Marcinkowskiego 1, 50-368 Wrocław, Poland.
Sawicz-Birkowska
Krystyna
K
Zaleska-Dorobisz
Urszula
U
Rabczyński
Jerzy
J
Jeleń
Michał
M
Apoznański
Wojciech
W
D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D007680:Kidney Neoplasms / Q000473:pathology* / Q000601:surgery*; D008297:Male; D018201:Nephroma, Mesoblastic / Q000473:pathology* / Q000601:surgery*; D011044:Poland; D016019:Survival Analysis; D016896:Treatment Outcome